A recent release by the University of Chicago Medical Center suggests that many patients with cancers in late stages receive chemotherapy and treatments that are ineffective when they should be seeking other solutions. These patients often end up facing high risks and costs when instead, they should be attempting to find appropriate clinical trials or treatment that specifically addresses their symptoms.
Learn More